Research & Development



  雲瑯看看劉徹咬咬牙道︰“太聰慧的人其實不適合當皇帝!”   霍光搖搖頭。97资源总站公开中文版   溫泉邊上的韭菜已經長到一尺長了,算不得翠綠,葉脈邊緣還有些泛黃,這是沒法子的事情,數九寒天里,能有綠菜吃已經很難得了,哪里能講究太多。免费视频在线视频观看1   眼看著金日的雙眼開始腫脹,鼻子開始流血,這才滿意的離開。   這支軍隊不用繼續操練,只需要根據平日里的名聲,以及武技的強弱,就能分辨出各級軍官,瞬間成軍。新超碰97在线观看   劉徹不願意談論這件事,見書記官已經將雲瑯奏對的話記錄下來了,就遣退書記官,低聲對雲瑯道︰“愛卿以為常山王可教否?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo